WASHINGTON, Nov. 18, 2020—Florida will be one of the first two states to receive the COVID-19 home test kits available by prescription.

Today, the U.S. Food and Drug Administration issued an emergency use authorization for the first COVID-19 diagnostic test for self-testing at home.

It will be available on a limited basis in Florida and California before being available nationwide by the spring.

The new Lucira All-In-One Test Kit provides rapid results within 30 minutes or less to determine if a person is positive or negative for the virus that causes COVID-19.

“While COVID-19 diagnostic tests have been authorized for at-home collection, this is the first that can be fully self-administered and provide results at home,” FDA Commissioner Stephen Hahn said in an FDA news release.

The test has been authorized for home use with self-collection nasal swab samples in individuals age 14 and older who are suspected of COVID-19 by their health care provider and is only available by prescription.

It is also authorized for use at doctors offices, hospitals, urgent care enter and emergency rooms for all ages, but samples must be collected by a healthcare provider for children under 14 years of age.